Inivata Limited, a pioneering company in the field of precision medicine, is headquartered in Great Britain (GB) and operates extensively across Europe and North America. Founded in 2014, Inivata has made significant strides in the oncology sector, focusing on the development of innovative liquid biopsy solutions that enhance cancer detection and monitoring. The company’s flagship product, Inivata's InVision platform, stands out for its ability to provide comprehensive genomic profiling through a simple blood test, offering unique insights into tumour dynamics. This technology positions Inivata as a leader in the liquid biopsy market, catering to both clinical and research applications. With a commitment to advancing cancer care, Inivata has achieved notable recognition for its contributions to the industry, solidifying its reputation as a key player in the evolving landscape of personalised medicine.
We don't have data for Inivata Limited, but we can show you information about their parent organization instead.
View parent company